Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vincent

Showing results (751-760 of 1,192) with videos related to

Pageof 120
Sort By:
The Lancet. Rheumatology|January 27, 2024
Safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of the oral TYK2 inhibitor PF-06826647 in participants with plaque psoriasis: a phase 1, randomised, double-blind, placebo-controlled, parallel-group studyChristopher Tehlirian, Elena Peeva, Elizabeth Kieras, et al.
Mayo Clinic Proceedings|June 9, 2012
Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general populationAngela Dispenzieri, Jerry A Katzmann, Robert A Kyle, et al.
Leukemia|April 25, 2020
Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myelomaHartmut Goldschmidt, Meletios A Dimopoulos, S Vincent Rajkumar, et al.
Blood|June 18, 2005
Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myelomaGrzegorz S Nowakowski, Thomas E Witzig, David Dingli, et al.
American Journal of Hematology|November 10, 2009
Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survivalMartha Q Lacy, Sumithra Mandrekar, Angela Dispenzieri, et al.
The Journal of Rheumatology|January 17, 2015
Elevation of serum immunoglobulin free light chains during the preclinical period of rheumatoid arthritisXiaoli Deng, Cynthia S Crowson, S Vincent Rajkumar, et al.
Blood|January 31, 2009
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective studyOla Landgren, Robert A Kyle, Ruth M Pfeiffer, et al.
European Journal of Haematology|June 8, 2012
Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantationJonathan S Bleeker, Morie A Gertz, Patricia A Pellikka, et al.
Forensic Science, Medicine, and Pathology|November 12, 2013
The neurocognitive effects of simulated use-of-force scenariosDonald M Dawes, Jeffrey D Ho, Andrea S Vincent, et al.
Blood|December 8, 2011
High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvementSumit Madan, Shaji K Kumar, Angela Dispenzieri, et al.
Pageof 120

Showing results (751-760 of 1,192) with videos related to

Sort By:
Pageof 120
The Lancet. Rheumatology|January 27, 2024
Safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of the oral TYK2 inhibitor PF-06826647 in participants with plaque psoriasis: a phase 1, randomised, double-blind, placebo-controlled, parallel-group studyChristopher Tehlirian, Elena Peeva, Elizabeth Kieras, et al.
Mayo Clinic Proceedings|June 9, 2012
Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general populationAngela Dispenzieri, Jerry A Katzmann, Robert A Kyle, et al.
Leukemia|April 25, 2020
Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myelomaHartmut Goldschmidt, Meletios A Dimopoulos, S Vincent Rajkumar, et al.
Blood|June 18, 2005
Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myelomaGrzegorz S Nowakowski, Thomas E Witzig, David Dingli, et al.
American Journal of Hematology|November 10, 2009
Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survivalMartha Q Lacy, Sumithra Mandrekar, Angela Dispenzieri, et al.
The Journal of Rheumatology|January 17, 2015
Elevation of serum immunoglobulin free light chains during the preclinical period of rheumatoid arthritisXiaoli Deng, Cynthia S Crowson, S Vincent Rajkumar, et al.
Blood|January 31, 2009
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective studyOla Landgren, Robert A Kyle, Ruth M Pfeiffer, et al.
European Journal of Haematology|June 8, 2012
Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantationJonathan S Bleeker, Morie A Gertz, Patricia A Pellikka, et al.
Forensic Science, Medicine, and Pathology|November 12, 2013
The neurocognitive effects of simulated use-of-force scenariosDonald M Dawes, Jeffrey D Ho, Andrea S Vincent, et al.
Blood|December 8, 2011
High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvementSumit Madan, Shaji K Kumar, Angela Dispenzieri, et al.
Pageof 120